Cargando…

Distinct classes and subclasses of antibodies to hemolysin co-regulated protein 1 and O-polysaccharide and correlation with clinical characteristics of melioidosis patients

Melioidosis is a tropical infectious disease caused by Burkholderia pseudomallei that results in high mortality. Hemolysin co-regulated protein 1 (Hcp1) and O-polysaccharide (OPS) are vaccine candidates and potential diagnostic antigens. The correlation of classes/subclasses of antibodies against th...

Descripción completa

Detalles Bibliográficos
Autores principales: Pumpuang, Apinya, Phunpang, Rungnapa, Ekchariyawat, Peeraya, Dulsuk, Adul, Loupha, Siriorn, Kwawong, Kochnipa, Charoensawat, Yaowaree, Thiansukhon, Ekkachai, Day, Nicholas P. J., Burtnick, Mary N., Brett, Paul J., West, T. Eoin, Chantratita, Narisara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764960/
https://www.ncbi.nlm.nih.gov/pubmed/31562344
http://dx.doi.org/10.1038/s41598-019-48828-4
_version_ 1783454473076604928
author Pumpuang, Apinya
Phunpang, Rungnapa
Ekchariyawat, Peeraya
Dulsuk, Adul
Loupha, Siriorn
Kwawong, Kochnipa
Charoensawat, Yaowaree
Thiansukhon, Ekkachai
Day, Nicholas P. J.
Burtnick, Mary N.
Brett, Paul J.
West, T. Eoin
Chantratita, Narisara
author_facet Pumpuang, Apinya
Phunpang, Rungnapa
Ekchariyawat, Peeraya
Dulsuk, Adul
Loupha, Siriorn
Kwawong, Kochnipa
Charoensawat, Yaowaree
Thiansukhon, Ekkachai
Day, Nicholas P. J.
Burtnick, Mary N.
Brett, Paul J.
West, T. Eoin
Chantratita, Narisara
author_sort Pumpuang, Apinya
collection PubMed
description Melioidosis is a tropical infectious disease caused by Burkholderia pseudomallei that results in high mortality. Hemolysin co-regulated protein 1 (Hcp1) and O-polysaccharide (OPS) are vaccine candidates and potential diagnostic antigens. The correlation of classes/subclasses of antibodies against these antigens with clinical characteristics of melioidosis patients is unknown. Antibodies in plasma samples from melioidosis patients and healthy donors were quantified by ELISA and compared with clinical features. In melioidosis patients, Hcp1 induced high IgG levels. OPS induced high IgG and IgA levels. The area under receiver operating characteristic curve (AUROCC) to discriminate melioidosis cases from healthy donors was highest for anti-Hcp1 IgG (0.92) compared to anti-Hcp1 IgA or IgM. In contrast, AUROCC for anti-OPS for IgG (0.91) and IgA (0.92) were comparable. Anti-Hcp1 IgG1 and anti-OPS IgG2 had the greatest AUROCCs (0.87 and 0.95, respectively) compared to other IgG subclasses for each antigen. Survivors had significantly higher anti-Hcp1 IgG3 levels than non-survivors. Male melioidosis patients with diabetes had higher anti-OPS IgA levels than males without diabetes. Thus, diverse and specific antibody responses are associated with distinct clinical characteristics in melioidosis, confirming the diagnostic utility of these responses and providing new insights into immune mechanisms.
format Online
Article
Text
id pubmed-6764960
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67649602019-10-02 Distinct classes and subclasses of antibodies to hemolysin co-regulated protein 1 and O-polysaccharide and correlation with clinical characteristics of melioidosis patients Pumpuang, Apinya Phunpang, Rungnapa Ekchariyawat, Peeraya Dulsuk, Adul Loupha, Siriorn Kwawong, Kochnipa Charoensawat, Yaowaree Thiansukhon, Ekkachai Day, Nicholas P. J. Burtnick, Mary N. Brett, Paul J. West, T. Eoin Chantratita, Narisara Sci Rep Article Melioidosis is a tropical infectious disease caused by Burkholderia pseudomallei that results in high mortality. Hemolysin co-regulated protein 1 (Hcp1) and O-polysaccharide (OPS) are vaccine candidates and potential diagnostic antigens. The correlation of classes/subclasses of antibodies against these antigens with clinical characteristics of melioidosis patients is unknown. Antibodies in plasma samples from melioidosis patients and healthy donors were quantified by ELISA and compared with clinical features. In melioidosis patients, Hcp1 induced high IgG levels. OPS induced high IgG and IgA levels. The area under receiver operating characteristic curve (AUROCC) to discriminate melioidosis cases from healthy donors was highest for anti-Hcp1 IgG (0.92) compared to anti-Hcp1 IgA or IgM. In contrast, AUROCC for anti-OPS for IgG (0.91) and IgA (0.92) were comparable. Anti-Hcp1 IgG1 and anti-OPS IgG2 had the greatest AUROCCs (0.87 and 0.95, respectively) compared to other IgG subclasses for each antigen. Survivors had significantly higher anti-Hcp1 IgG3 levels than non-survivors. Male melioidosis patients with diabetes had higher anti-OPS IgA levels than males without diabetes. Thus, diverse and specific antibody responses are associated with distinct clinical characteristics in melioidosis, confirming the diagnostic utility of these responses and providing new insights into immune mechanisms. Nature Publishing Group UK 2019-09-27 /pmc/articles/PMC6764960/ /pubmed/31562344 http://dx.doi.org/10.1038/s41598-019-48828-4 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Pumpuang, Apinya
Phunpang, Rungnapa
Ekchariyawat, Peeraya
Dulsuk, Adul
Loupha, Siriorn
Kwawong, Kochnipa
Charoensawat, Yaowaree
Thiansukhon, Ekkachai
Day, Nicholas P. J.
Burtnick, Mary N.
Brett, Paul J.
West, T. Eoin
Chantratita, Narisara
Distinct classes and subclasses of antibodies to hemolysin co-regulated protein 1 and O-polysaccharide and correlation with clinical characteristics of melioidosis patients
title Distinct classes and subclasses of antibodies to hemolysin co-regulated protein 1 and O-polysaccharide and correlation with clinical characteristics of melioidosis patients
title_full Distinct classes and subclasses of antibodies to hemolysin co-regulated protein 1 and O-polysaccharide and correlation with clinical characteristics of melioidosis patients
title_fullStr Distinct classes and subclasses of antibodies to hemolysin co-regulated protein 1 and O-polysaccharide and correlation with clinical characteristics of melioidosis patients
title_full_unstemmed Distinct classes and subclasses of antibodies to hemolysin co-regulated protein 1 and O-polysaccharide and correlation with clinical characteristics of melioidosis patients
title_short Distinct classes and subclasses of antibodies to hemolysin co-regulated protein 1 and O-polysaccharide and correlation with clinical characteristics of melioidosis patients
title_sort distinct classes and subclasses of antibodies to hemolysin co-regulated protein 1 and o-polysaccharide and correlation with clinical characteristics of melioidosis patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764960/
https://www.ncbi.nlm.nih.gov/pubmed/31562344
http://dx.doi.org/10.1038/s41598-019-48828-4
work_keys_str_mv AT pumpuangapinya distinctclassesandsubclassesofantibodiestohemolysincoregulatedprotein1andopolysaccharideandcorrelationwithclinicalcharacteristicsofmelioidosispatients
AT phunpangrungnapa distinctclassesandsubclassesofantibodiestohemolysincoregulatedprotein1andopolysaccharideandcorrelationwithclinicalcharacteristicsofmelioidosispatients
AT ekchariyawatpeeraya distinctclassesandsubclassesofantibodiestohemolysincoregulatedprotein1andopolysaccharideandcorrelationwithclinicalcharacteristicsofmelioidosispatients
AT dulsukadul distinctclassesandsubclassesofantibodiestohemolysincoregulatedprotein1andopolysaccharideandcorrelationwithclinicalcharacteristicsofmelioidosispatients
AT louphasiriorn distinctclassesandsubclassesofantibodiestohemolysincoregulatedprotein1andopolysaccharideandcorrelationwithclinicalcharacteristicsofmelioidosispatients
AT kwawongkochnipa distinctclassesandsubclassesofantibodiestohemolysincoregulatedprotein1andopolysaccharideandcorrelationwithclinicalcharacteristicsofmelioidosispatients
AT charoensawatyaowaree distinctclassesandsubclassesofantibodiestohemolysincoregulatedprotein1andopolysaccharideandcorrelationwithclinicalcharacteristicsofmelioidosispatients
AT thiansukhonekkachai distinctclassesandsubclassesofantibodiestohemolysincoregulatedprotein1andopolysaccharideandcorrelationwithclinicalcharacteristicsofmelioidosispatients
AT daynicholaspj distinctclassesandsubclassesofantibodiestohemolysincoregulatedprotein1andopolysaccharideandcorrelationwithclinicalcharacteristicsofmelioidosispatients
AT burtnickmaryn distinctclassesandsubclassesofantibodiestohemolysincoregulatedprotein1andopolysaccharideandcorrelationwithclinicalcharacteristicsofmelioidosispatients
AT brettpaulj distinctclassesandsubclassesofantibodiestohemolysincoregulatedprotein1andopolysaccharideandcorrelationwithclinicalcharacteristicsofmelioidosispatients
AT westteoin distinctclassesandsubclassesofantibodiestohemolysincoregulatedprotein1andopolysaccharideandcorrelationwithclinicalcharacteristicsofmelioidosispatients
AT chantratitanarisara distinctclassesandsubclassesofantibodiestohemolysincoregulatedprotein1andopolysaccharideandcorrelationwithclinicalcharacteristicsofmelioidosispatients